Published in Lab Law Weekly, May 18th, 2007
The Board of the Company has therefore resolved to seek shareholder approval to reduce the Company's share capital by the cancellation of its 93,553,394 Deferred Shares of 5p each (the "Deferred Shares") and cancel its share premium account at the forthcoming annual general meeting of the Company to be held on 6 June 2007.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.